Manufacturer/Distributor: Novolet Novo Nordisk/Transcom
Side effects: Local reactions and lipo-atrophy at the site of injection; overdose causes hypoglycaemia (signs are vomiting specially in children, palpitation, trembling, sweating, tingling in the hands or lip, pallor, impaired visioin, listlessness, confusion and dizzi
Precautions and warnings: Dosages require proper adjustment druing infections, pregnancy, emotional distress, change in species of origin, type or purity of insulin. Besides insulin requirements may increase during concomitant therapy with thyroxine, corticosteroids and MAOIs may e
Pregnancy category:Not categorized yet
Therapeutic class: Insulin prepns
Dosage and administrations: Adult Child: By s.c, i.m or i. v injection. Dosage according to individual requirments initially be determined by the physician. There is no fixed rules for insulin dosage, adjustment in dosages is needed to achieve and maintain desired blood glucose
Indication: 1 . In all cases of Insulin dependent Diabetes mellitus (100M) 2. In Non-Insulin dependent Diabetes mellitus (NIDDM) whenever good control with diet and oral hypoglycemic agent is no longer attainable (e.g. secondary failure with sulphonylurea therapy). 3
Composition action: Hypoglycaemia. Hypersensitivity to the active substances or to any of the excipients.